Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Neurvati Appoints J. Michael Ryan As Chief Medical Officer and Elliott Ruiz As Chief Financial Officer
PRIVATEAug 05, 2026•4 days ago
Position
Chief Financial Officer
Company
Neurvati Neurosciences
Elliott Ruiz
New YorkBiotechnologyHealth CareTherapeutics
Description
Neurvati Neurosciences has appointed J. Michael Ryan, M.D., as Chief Medical Officer and promoted Elliott Ruiz to Chief Financial Officer. These leadership changes strengthen Neurvati's executive team to support the advancement of GRIN Therapeutics' neuroscience development efforts.
Company Information
Company
Neurvati Neurosciences
Location
New York, New York, United States
About
Neurvati Neurosciences is a clinical-stage biotechnology company dedicated to bringing a new generation of proven-effective therapies to people affected by neurological and psychiatric disorders. The company collaborates to support rapid late-stage development of innovative treatments to improve the lives of patients.
Predictive Intelligence
Strategic
ML-powered predictions for Neurvati Neurosciences's next move
New YorkBiotechnologyHealth CareTherapeutics